A claim you hear on longevity podcasts

Do NAD supplements fail to slow aging?

Leaning for. Of 10 studies that test it, 7 partly agree, 2 agree and 1 disagrees.

Best for:
Anyone paying for NMN or NR to slow aging
Price:
Free to read, with every receipt. Pro is $9 a month or $79 a year and adds AI Ask.

The claim checked: NAD boosters such as NR and NMN won't slow aging in healthy people Hear it at 1:57:55

PrecisRECEIPT FOR A CLAIM


Do NAD supplements fail to slow aging?


  • 3 × TrialPARTLY
  • 3 × StudyPARTLY
  • 1 × TrialAGREE
  • 1 × Combined analysisAGREE
  • 1 × Combined analysisPARTLY
  • 1 × TrialDISAGREE

TOTAL2 AGREE / 7 PARTLY / 1 DISAGREE

Leaning for

What do the studies say?

Leaning for

Of 10 studies, 2 agree, 1 disagrees and 7 partly agree. A pooled analysis of trials in adults over 60 found NMN and NR did not improve muscle mass or function. In 12 healthy men aged 70-80, NR raised NAD in muscle but did not change heart or metabolic health. A trial in 80 adults aged 40-65 in India found NMN improved walking distance and a blood test of biological age. Most trials partly agree: they found a gain on one measure, such as strength or blood pressure, but not on others, and called for bigger studies. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are building blocks the body turns into NAD.

Computed from 10 studies that test this point, each judged by two readers, in full. 5 more studies are waiting for a full read and do not count yet.

What was said on the podcast?

“I just don't see how and it's based on mitochondrial dysfunction causes the mitochondria not to regenerate NAD because that's what mitochondria do let's give NAD supplements”
Nav Chandel, a guest on The Drive · 416 ‒ The science of mitochondria: their role in health, aging, disease, and much more · 1:57:55 on YouTube
Episode check NAD boosters won't slow aging, the episode says. Of 10 studies, 2 agree, 1 disagrees and 7 partly agree. 6 claims checked against 59 studies · 22 chapters not checked yet See the whole episode →
The point checked Leaning for

NAD precursor supplements (NR or NMN) do not slow aging or improve age-related health in otherwise healthy people

Agree 2

pooled analysis · 2025

“In conclusion, current evidence does not support the use of NMN and NR as effective interventions for improving muscle function and mass in adults above 60 years old.”

The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. J Cachexia Sarcopenia Muscle
Who: Placebo-controlled RCTs of adults with mean age 60 years or more, any health status (community-dwelling, type 2 diabetes, prediabetes, obesity, mild cognitive impairment, peripheral artery disease); mean age 60.9-83 years
PMID 40275690

controlled trial · 2019 · landmark

“We report that oral NR augments the aged human skeletal muscle NAD + metabolome while inducing a transcriptional signature without affecting mitochondrial function or systemic cardiometabolic parameters.”

Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Rep
Who: 12 otherwise healthy men aged 70-80 years (median age 75, median BMI 26.6) from the Birmingham 1000 Elders group, without diabetes, ischemic heart disease or other serious conditions
PMID 31412242

Partly agree 7

other primary study · 2022 · landmark

“These findings indicate that the chronic oral supplementation of NMN partly improved the muscle strength and performance in healthy older men, although NMN did not affect the skeletal muscle mass.”

Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging
Who: 42 healthy Japanese men aged 65 years or more (BMI 22-28, nonsmokers, no active disease) randomized to NMN or placebo; only 20 had valid 12-week data
PMID 35927255

controlled trial · 2022

“There was no statistically significant interaction in sleep quality as assessed by the PSQI.”

Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients
Who: 108 community-dwelling Japanese adults aged 65 years or more in Tsukuba, without dementia, randomized to NMN or placebo taken in the morning or the evening
PMID 35215405

other primary study · 2022

“The analysis of the data obtained in this study did not find any statistically significant changes in efficacy outcomes between the active and placebo groups.”

A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults. Front Aging
Who: Healthy adults aged 40-65 years (BMI 18.5-35) in Pune, India; mean age about 47, mostly women
PMID 35821806

pooled analysis · 2026

“Current evidence does not show broad and consistent improvements in conventional metabolic indicators such as body weight, BMI, glycemia, lipids, or systolic blood pressure.”

Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients
Who: Adult RCTs of oral NMN: healthy adults, healthy middle-aged and older adults, recreational runners, overweight or obese adults, prediabetes or type 2 diabetes, mild hypertension, and one trial of hospitalized adults with COVID-19 and acute kidney injury
PMID 42514320

Show 3 more Show fewer

controlled trial · 2023

“The improvements in several cardiovascular risk factors—total and LDL cholesterol, diastolic blood pressure, and body weight—observed in this physiologic study need confirmation in larger trials of longer duration.”

Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study. J Clin Endocrinol Metab
Who: Community-dwelling overweight or obese (BMI 25-42.5) men and postmenopausal women aged 45 years or older without diabetes or significant medical problems; mean age 61.9
PMID 36740954

controlled trial · 2023

“However, no significant difference was observed in the average baPWV values between the two groups ( p = 0.097).”

Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Sci Rep
Who: Apparently healthy Japanese men and women aged 40-59 years (no diabetes or serious comorbidity), mean age about 48
PMID 36797393

other primary study · 2023 · landmark

“The open study setting and the lack of a statistically powered placebo group may compromise our results related to body composition and metabolic health, and these endpoints need to be followed up in larger placebo-controlled trials.”

Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. Sci Adv
Who: Finnish monozygotic twins aged ~40 (IQR 33 to 41), mostly overweight or obese (mean BMI ~30-32) and largely metabolically healthy: 16 BMI-discordant pairs (all on NR) and 4 BMI-concordant pairs (one cotwin NR, one placebo)
PMID 36638183

Disagree 1

controlled trial · 2023

“NMN supplementation had a positive impact on the physical endurance and general health conditions of healthy adults as demonstrated in the significant improvement of six-minute walking test, blood biological age, and SF-36 scores.”

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience
Who: 80 healthy men and women aged 40-65 years (BMI 18.5-35) in Pune, India; mean age 49.3, 59% female
PMID 36482258

More on supplements and drugs

The Precis Weekly

Get each new check by email.

One email a week with the claims and episodes we checked, what the studies found and the minute each claim was said.

Free. Unsubscribe anytime.